Request Trial

Biotech news

Reset all filters
Geography
Company
Refine search
Harvard, 10x accuse NanoString of infringing gene sequencing tech
Biotech
Harvard, 10x accuse NanoString of infringing gene sequencing tech
Harvard College and 10x Genomics have sued Nanostring Technologies, alleging that the company’s CosMx imaging platform infringes two patents covering “gene-mapping” technology.   3 March 2022
USPTO rules Broad owns CRISPR animal cell editing patents
Americas
USPTO rules Broad owns CRISPR animal cell editing patents
Patents core to the breakthrough gene-editing technology CRISPR belong to the University of Harvard and the Massachusetts Institute of Technology’s Broad Institute, the US Patent and Trademark Office has ruled.   1 March 2022
When alliances fail, is arbitration the answer?
Africa
When alliances fail, is arbitration the answer?
The global pandemic has increased collaboration and a new wave of disputes is likely. Arbitration is well placed to help, argue Kate Davies McGill, Gaela Gehring Flores and Paul Keller of Allen & Overy   24 February 2022
Biotech
UN International Day of Women and Girls in Science: a perspective
Chiara Banas, patent scientist at EIP, queries the gender gap in life sciences, and shares how her own experiences could prefigure change.   10 February 2022
Biotech
ITC to investigate Alvotech’s Humira biosimilar
The US International Trade Commission will investigate whether drug manufacturers used trade secrets to develop a biosimilar of AbbVie’s Humira.   27 January 2022
Biotech
Pandemic blues: the global approach to COVID-related IP
While the effort to secure greater vaccine and treatment equality via an IP waiver is admirable, it could stifle innovation and create long-term problems, say Matthew Howell and Lauren Griffin of Alston & Bird.   20 January 2022
Biotech
AstraZeneca inks $730m licensing deal for rare heart disease treatment
Alexion, AstraZeneca’s rare disease group, has entered into an exclusive licensing agreement with Neurimmune AG for NI006, an antibody in development for the treatment of the heart condition, transthyretin amyloid cardiomyopathy.   11 January 2022
Biotech
Allele drops COVID-19 protein suit against Pfizer, BioNTech
Biotech Allele has dropped its lawsuit accusing Pfizer and BioNTech of infringing technology covering a fluorescent protein used in COVID-19 vaccines.   6 January 2022
Biotech
AbbVie wants USITC to investigate Alvotech over Humira ‘theft’
AbbVie seeks to block imports of Alvotech’s biosimilar Humira into the US, claiming that the Icelandic company plundered former employees and used its trade secrets to develop the drug.   21 December 2021
Biotech
NextCure targeted in cancer drug trade secrets suit
Public biopharmaceutical company NextCure has been accused of misappropriating trade secrets in order to create a direct competitor to a biotech’s cancer immunotherapy technology.   16 December 2021